Revenue
$20.61B
Gross Margin
+70.4%
Operating Margin
+20.1%
Net Margin
+17.2%
Income statement waterfall for Boston Scientific (BSX) — TTM through Q1 2026
Net income: $3.55B
Margin breakdown for Boston Scientific (BSX) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $20.61B | $20.61B |
| Cost of Revenue | −$6.10B | $14.52B |
| Gross Profit | $14.52B | $14.52B |
| Operating Expenses | −$10.37B | $4.15B |
| Operating Income | $4.15B | $4.15B |
| Other Income / Expense | −$405.00M | $3.74B |
| Pre-tax Income | $3.74B | $3.74B |
| Income Tax | −$184.00M | $3.56B |
| Net Income | $3.55B | $3.55B |
- Revenue$20.61B
- Cost of Revenue−$6.10B
- Gross Profit$14.52B
- Operating Expenses−$10.37B
- Operating Income$4.15B
- Other Income / Expense−$405.00M
- Pre-tax Income$3.74B
- Income Tax−$184.00M
- Net Income$3.55B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement